Pro-elastogenic effects of bone marrow mesenchymal stem cell-derived smooth muscle cells on cultured aneurysmal smooth muscle cells
- 6 November 2014
- journal article
- research article
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 11 (3) , 679-693
Abstract
Abdominal aortic aneurysms (AAAs) involve slow proteolysis and loss of structural matrix components (collagen and elastin), which lead to wall thinning, weakening and ultimate rupture. At this time, no established non-surgical therapy is available to slow or arrest AAA growth. Inhibiting matrix metalloproteases (MMPs; e.g. MMP2 and −9) overexpressed within AAAs is insufficient to arrest AAA growth, since resident smooth muscle cells (SMCs) are poorly elastogenic and cannot overcome elastolysis to reinstate a healthy elastic matrix. Towards overcoming this limitation, this first study sought to determine the utility of rat bone marrow mesenchymal stem cell (BM-MSC)-derived SMCs to stimulate elastin and elastic matrix synthesis and assembly by aneurysmal SMCs (EaRASMCs). BM-MSCs were successfully differentiated into cells of an SMC lineage (SMLCs). Our study indicates that BM-MSC-derived SMLCs secrete trophic factors, contained in conditioned medium (CM) from their cultures, that, when exposed to EaRASMC cultures in real time, stimulate elastin precursor and matrix deposition and crosslinking by these elastogenically deficient cells, with added benefits in terms of attenuating MMPs, specifically MMP9. The results thus lend support to a proposed cell therapy for AAAs, based on the use of BM-MSC-derived SMLCs. Although we observed no particular improvement in elastic fibre formation, no attenuation of MMP2 activity and increase in amounts of active MMP2 enzyme, we believe that this study justifies follow-up studies to improve upon these outcomes. Future studies will explore the effects of concentrated CM collected from long-term SMLC cultures on EaRASMCs and also investigate the elastogenic output of SMLCs themselves. Copyright © 2014 John Wiley & Sons, Ltd.Keywords
Funding Information
- National Institutes of Health (HL092051)
- American Heart Association (GRNT17080027)
This publication has 70 references indexed in Scilit:
- Intravenous administration of mesenchymal stem cells prevents angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouseJournal of Translational Medicine, 2013
- Induced Elastic Matrix Deposition Within Three-Dimensional Collagen ScaffoldsTissue Engineering Part A, 2011
- Aligned electrospun scaffolds and elastogenic factors for vascular cell-mediated elastic matrix assemblyJournal of Tissue Engineering and Regenerative Medicine, 2011
- Evaluating Smooth Muscle Cells from CaCl 2 -Induced Rat Aortal Expansions as a Surrogate Culture Model for Study of Elastogenic Induction of Human Aneurysmal CellsTissue Engineering Part A, 2011
- Elastogenic Inductability of Smooth Muscle Cells from a Rat Model of Late Stage Abdominal Aortic AneurysmsTissue Engineering Part A, 2011
- Advances in Reprogramming Somatic Cells to Induced Pluripotent Stem CellsStem Cell Reviews and Reports, 2010
- Transforming Growth Factor Beta 1 and Hyaluronan Oligomers Synergistically Enhance Elastin Matrix Regeneration by Vascular Smooth Muscle CellsTissue Engineering Part A, 2009
- Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR dataNucleic Acids Research, 2009
- A Comparison of Murine Smooth Muscle Cells Generated from Embryonic versus Induced Pluripotent Stem CellsStem Cells and Development, 2008
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001